RBRainer Buchholz

Rainer Buchholz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rainer Buchholz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemical regulation of Fea1 driven transgene expression in Chlamydomonas reinhardtii

    by Paula Barjona Do Nascimento Coutinho, Christine Friedl, Rainer Buchholz, Stephanie Christine Stute


  • Prolonged Ex vivo expansion and differentiation of naïve murine CD43− B splenocytes

    by Kenny Zambrano, Valérie Jérôme, Ruth Freitag, Rainer Buchholz, Hans‐Martin Jäck, Holger Hübner, Wolfgang Schuh

    Ex vivo expansion of naive primary B cells is still a challenge, yet would open new possibilities for in vitro studies of the immune response or the production of monoclonal antibodies. In our hands, unstimulated murine B cells did not expand in significant numbers, while culture viability decreased rapidly within a few days. Activation mimicking in vivo stimulation through either T cell‐independent or T‐cell dependent signaling, led to several division cycles, albeit accompanied by irreversible differentiation. By co‐culturing B cells under moderate hypothermia (30°C) on live feeder fibroblasts expressing recombinant CD40 ligand (CD154) and by repeatedly transferring cultured B cells to new feeder cell cultures, we could extend the growth of primary mouse B cells compared to cultures maintained at 37°C. B cells under these conditions showed an activated phenotype as shown by the presence of AID and IRF4, two factors required for IgH class switch recombination in antigen‐activated B cells. In contrast to cells cultured at 37°C, B cells under hyperthermia did surprisingly not differentiate into Blimp‐1 expressing plasmablasts. Thus, the repeated batch process under hyperthermic conditions represents a first step towards the development of a continuous cultivation system for the expansion of primary B cells. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:978–989, 2016


  • Cell retention by encapsulation for the cultivation of Jurkat cells in fixed and fluidized bed reactors

    by P. Kaiser, M. Werner, V. Jérôme, H. Hübner, R. Buchholz, R. Freitag

    Jurkat cells are accepted model cells for primary human T lymphocytes, for example, in medical research. Their growth to tissue‐like cell densities (up to 100 × 106 cells/mLcapsule) in semi‐permeable (molecular weight cut off 6 cell/gcapsule. At the same time, the cell cycle distribution of the cells was shifted to the S and G2/M phases. Biotechnol. Bioeng. 2014;111: 2571–2579.